Synonyms: IBI-306 | IBI306 | Sintbilo®
tafolecimab is an approved drug (China (2023))
Compound class:
Antibody
Comment: Tafolecimab (IBI-306; Innovent Biologics) is a fully human proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody. Based on protein sequence alignments, we suspect that tafolecimab is one of the monoclonals that are claimed in Innovent Biologics' patent US11485795: Anti-PCSK9 antibody and use thereof [4].
|
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|